Armata Pharmaceuticals, Inc.
ARMP
$1.87
-$0.14-6.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.90% | 113.10% | 82.41% | 353.34% | -72.68% |
| Total Depreciation and Amortization | 18.93% | 29.69% | 41.63% | 38.16% | 37.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.45% | -211.06% | -113.04% | -225.84% | 293.43% |
| Change in Net Operating Assets | 29.26% | 113.46% | -1,116.30% | 77.71% | 76.91% |
| Cash from Operations | 28.38% | 2.21% | 8.51% | 15.61% | 39.76% |
| Capital Expenditure | 60.40% | 103.21% | 90.32% | -515.32% | 87.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 60.40% | 103.22% | 90.32% | -515.32% | 87.56% |
| Total Debt Issued | -71.34% | -- | -100.00% | 100.00% | 17.89% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.41% | 100.00% | -100.25% | 123.91% | 18.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.43% | 25.51% | -179.82% | 9.45% | 140.63% |